Pontine Demyelination and Incontinence
Yes, pontine demyelination (central pontine myelinolysis) can cause urinary incontinence, and this may be the presenting symptom. While the evidence base is limited, case reports demonstrate that CPM can manifest as new-onset urinary incontinence with loss of bladder sensation 1.
Mechanism and Clinical Presentation
The pons contains critical micturition control centers, and demyelination in this region disrupts the neurological pathways controlling bladder function. In the documented case, an 84-year-old patient developed:
- New-onset urinary incontinence
- Complete loss of awareness of bladder filling
- Inability to sense bladder fullness
- Enlarged bladder on imaging 1
This represents neurogenic lower urinary tract dysfunction (NLUTD) caused by pontine pathology, fitting the definition of abnormal bladder, bladder neck, and/or sphincter function related to a neurologic disorder 2, 3.
Regarding Fecal Incontinence
The available evidence does not specifically address fecal incontinence in CPM. However, the AUA/SUFU guidelines acknowledge that "bowel dysfunction is common in patients with NLUTD" 2, 3, though this is noted to be outside their scope. Given that pontine lesions affect autonomic control pathways, fecal incontinence is biologically plausible but lacks direct documentation in the CPM literature.
Clinical Implications
Diagnostic Considerations
When evaluating new-onset incontinence in at-risk patients (those with rapid osmolar shifts from hyperglycemia, hyponatremia correction, or liver transplantation 1, 4):
- Obtain brain MRI to evaluate for pontine lesions—this is the diagnostic modality of choice 4
- Check post-void residual to assess bladder emptying 3
- Perform detailed neurological examination for other pontine signs (dysarthria, dysphagia, quadriparesis, altered consciousness)
- Review recent electrolyte history and osmolar changes
Important Caveats
The biphasic clinical course of ODS is critical to recognize 4. Patients may initially present with symptoms of the underlying condition (hyponatremia, hyperglycemia), then develop neurological manifestations including incontinence days later as demyelination progresses. This delayed presentation can lead to missed diagnoses if clinicians don't maintain vigilance.
CPM presenting solely as urinary incontinence is rare 1, so other causes must be excluded, particularly cauda equina syndrome in appropriate clinical contexts.
Management Approach
For patients with CPM-related incontinence, apply NLUTD management principles 2:
- Implement intermittent catheterization rather than indwelling catheters for bladder emptying (strong recommendation)
- Consider antimuscarinics or beta-3 agonists for storage symptoms
- Monitor for urinary tract infections
- Assess for upper tract deterioration with appropriate follow-up
Prevention remains the primary strategy 4, as treatment options for established CPM are experimental. The prognosis is guarded, with 33-55% of patients either dying or remaining permanently dependent on nursing care 4.